Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Long-term clinical outcomes and analyses of atezolizumab for mTNBC

Prof Peter Schmid - Barts Cancer Institute, London, UK

Long-term clinical outcomes and analyses of atezolizumab for mTNBC ( Prof Peter Schmid - Barts Cancer Institute, London, UK )

Checkmate 067 - combined nivolumab and ipilimumab

Dr Suzanne Topalian - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA

Checkmate 067 - combined nivolumab and ipilimumab ( Dr Suzanne Topalian - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

Durable responses to avelumab in patients with Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA

Durable responses to avelumab in patients with Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )

Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker...

Prof Peter Schmid - Barts Cancer Institute, London, UK

Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses ( Prof Peter Schmid - Barts Cancer Institute, London, UK )

Five-year follow-up of nivolumab in NSCLC

Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA

Five-year follow-up of nivolumab in NSCLC ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

Mechanisms of resistance in triple negative breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

Mechanisms of resistance in triple negative breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

IMW 2017 highlights

Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France

IMW 2017 highlights ( Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France )

Treatment of multiple myeloma patients in the relapsed setting: Expert...

Prof Maria-Victoria Mateos, Prof Paul Richardson

Treatment of multiple myeloma patients in the relapsed setting: Expert discussion from IMW 2017 ( Prof Maria-Victoria Mateos, Prof Paul Richardson )

Multiple myeloma highlights from IMW 2017

Prof Phillipe Moreau, Prof Philip McCarthy, Prof Jens Hillengass, Prof Meletios...

Multiple myeloma highlights from IMW 2017 ( Prof Phillipe Moreau, Prof Philip McCarthy, Prof Jens Hillengass, Prof Meletios Dimopoulos )

Role of immunotherapy and precision medicines in multiple myeloma and key new...

Prof Sagar Lonial - Emory University, Atlanta, USA

Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines ( Prof Sagar Lonial - Emory University, Atlanta, USA )

Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple...

Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece

Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )

Monoclonal antibodies in multiple myeloma

Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain

Monoclonal antibodies in multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )

More from ecancer